Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2002
10/03/2002WO2002077168A2 Mch1r deficient mice
10/03/2002WO2002077167A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/03/2002WO2002077152A1 Device and method for detection of multiple analytes
10/03/2002WO2002077031A1 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same,
10/03/2002WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002WO2002077023A2 A new essential downstream component of the wingless signalling pathway
10/03/2002WO2002077022A1 Immunogenic cell surface proteins of helicobacter pylori
10/03/2002WO2002077016A2 Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore
10/03/2002WO2002077013A2 Human secreted proteins
10/03/2002WO2002077012A2 Human papilloma virus immunoreative peptides
10/03/2002WO2002076987A1 (oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides
10/03/2002WO2002076921A1 Gallic acid derivatives and use for exploring endogenetic coagulation
10/03/2002WO2002076608A2 Method for producing an array for detecting constituents from a biological sample
10/03/2002WO2002076584A1 Method and device for assessing the operability of a device for reducing the ozone content in the air
10/03/2002WO2002076503A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
10/03/2002WO2002076501A2 Blood cell production via activation of the hemoglobin scavenger receptor
10/03/2002WO2002076489A1 Serum albumin binding moieties
10/03/2002WO2002076482A2 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
10/03/2002WO2002076477A1 Skin-test reagents and serum specific ige, igg subtypes detection kits, comprising crude extracts of spider mites such as citrus red mite, two-spotted spider mite and european red mite
10/03/2002WO2002076467A1 Compositions and methods to regulate bone and mineral metabolism
10/03/2002WO2002076466A1 Compositions and methods for negative regulation of tgf-beta pathways
10/03/2002WO2002076437A2 Methods for treating neurodegenerative diseases including alzheimer's
10/03/2002WO2002076383A2 Securin is required for chromosomal stability in human cells
10/03/2002WO2002076380A2 Cytotoxic factors for modulating cell death
10/03/2002WO2002076377A2 Mononucleosome and process for producing the same, method of assaying antibody specific to nucleosome, method of diagnosing autoimmune disease, process for producing nucleosome dna, dna plate, process for producing dna plate and method of assaying anti-dna antibody
10/03/2002WO2002076343A1 Method and kit for quantitation of histidine-tagged polypeptides
10/03/2002WO2002076286A2 Prognostic methods for breast cancer
10/03/2002WO2002076280A2 Methods and kits for determing a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer
10/03/2002WO2002076248A2 Customized therapeutics and in situ diagnostics
10/03/2002WO2002076203A2 Method and system for preparing tissue samples for histological and pathological examination
10/03/2002WO2002068687A8 Function and application of tob gene in central nervous system of mammal
10/03/2002WO2002063939A3 Method and system for fecal and ingesta detection during meat and poultry processing
10/03/2002WO2002062297A3 Methods and compositions for modulating gluconeogenesis using pgc-1
10/03/2002WO2002059559A3 Hydrocarbon sensor
10/03/2002WO2002057248A3 Inhibitors of cruzipain and other cysteine proteases
10/03/2002WO2002054052A9 Diagnostic instruments and methods for detecting analytes
10/03/2002WO2002053231A3 Method and device for gevondyan and zharov photo-immune- modulating therapy
10/03/2002WO2002044723A3 Method for diagnosing a predisposition of psychosis in a progeny
10/03/2002WO2002034933A3 Methods and compositions for modifying biologically active target molecules
10/03/2002WO2002029086A3 Nucleic acid sequences differentially expressed in cancer tissue
10/03/2002WO2002026193A3 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
10/03/2002WO2002024907A3 G-protein coupled receptor hfrbn63
10/03/2002WO2002024896A9 Screening assays for agonists or antagonists of receptor activat or of nf-kb
10/03/2002WO2002018407A3 Antisense oligonucleotides against vanilloid receptor 1
10/03/2002WO2002013961A3 Chemical screening system using strip arrays
10/03/2002WO2002004949A3 Reagents and methods for identification of binding agents
10/03/2002WO2002002585A3 Low fluorescence nylon/glass composites for microdiagnostics
10/03/2002WO2001098355A3 Cgi-69 compositions and methods of use
10/03/2002WO2001096608A8 Detection of nucleic acids by type-specific hybrid capture method
10/03/2002WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002WO2001094925A8 Gas detection sensor
10/03/2002WO2001094627A3 Assay techniques based on growth stage dependent expression in c. elegans
10/03/2002WO2001092870A3 Kit and method for determining a plurality of analytes
10/03/2002WO2001092561A3 Method of screening for negative cross resistance
10/03/2002WO2001085983A3 Methods for testing compounds useful for treating diabetic complications
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001027857A3 Methods for generating databases and databases for identifying polymorphic genetic markers
10/03/2002WO2001026038A9 Methods of imaging colloidal rod particles as nanobar codes
10/03/2002WO2001023878A9 System and method of assessing the structural properties of wooden members using ultrasound
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2001020331A9 Substrates and screening methods for transport proteins
10/03/2002WO2001020326A9 Materials and methods for the determination of an analyte
10/03/2002WO2001020323A9 Methods and systems for counting particles and sensing water
10/03/2002WO2001017343A9 Methods for evaluating a compound for its effect on skin
10/03/2002WO2001007890A3 A method of controlling the temperature of a specimen in or on a solid support member
10/03/2002WO1999047923A3 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
10/03/2002US20020143475 Management method of probe carrier, probe carrier manufacturing apparatus and probe carrier managing apparatus
10/03/2002US20020143472 Method and display for multivariate classification
10/03/2002US20020143298 Blunt cannula and filter assembly and method of use with point-of-care testing cartridge
10/03/2002US20020143297 Adaptor for use with point-of-care testing cartridge
10/03/2002US20020143293 Adaptor for use with point-of-care testing cartridge
10/03/2002US20020143274 Adaptor for use with point-of-care testing cartridge
10/03/2002US20020143273 Adaptor for use with point-of-care testing cartridge
10/03/2002US20020143272 Method and kit of components for delivering blood to a portable clinical analyzer
10/03/2002US20020143271 Walled adaptor for use with point-of-care testing kit
10/03/2002US20020143163 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (DHCP), the protein encoded by same, and applications thereof
10/03/2002US20020143162 Methods
10/03/2002US20020143155 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
10/03/2002US20020143153 Monitoring crystalization on microarray; generate microarray, incubate with sample of mother liquor, detect crystal formation in the drops, take images of drops
10/03/2002US20020143150 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical composition and a diagnostic reagent comprising the same
10/03/2002US20020143111 High density, miniaturized arrays and methods of manufacturing same
10/03/2002US20020143110 High density, miniaturized arrays and methods of manufacturing same
10/03/2002US20020143105 Providing test sample comprising a polypeptide that contains a discordant helix in form of alpha-helix; contacting test sample with test compound; determining rate of decrease amount of alpha -helix in ttest sample
10/03/2002US20020142986 Used in the diagnosis or prognosis of liver associated disorders
10/03/2002US20020142961 As pharmaceuticals, diagnostics, biosensors and bioreactors
10/03/2002US20020142939 HMGI proteins in cancer and obesity
10/03/2002US20020142909 Centrifuge bowl for separating particles
10/03/2002US20020142844 Biometric broadband gaming system and method
10/03/2002US20020142485 Immunological analytical method and device for the determination of glycosylated protein
10/03/2002US20020142484 Synthetic tracer for use in the detection of tetrahydrocannabinols and cannabinol
10/03/2002US20020142483 Transferring liquid samples to substrate; dip pin tool into sample reservoir, withdraw liquid, expell liquid on to substrate at target positioning, monitor substrate and sample
10/03/2002US20020142481 Apparatus for use in the detection of preferential particles in fluids
10/03/2002US20020142477 Spatiotemporal and geometric optimization of sensor arrays for detecting analytes fluids
10/03/2002US20020142476 Measure dry-weight of carbohydrates in sample; obtain carbohydrate sample, expose to nuclear magnetic resonance, measure the amount carbohydrate in sample
10/03/2002US20020142473 Fluorescent labeling method and substrate
10/03/2002US20020142472 Tissue-based standoff biosensors for detecting chemical warfare agents
10/03/2002US20020142469 Detecting leak in sealed optical apparatus; obtain apparatus, inject gas, insert sealed apparatus into testing container, heat, detect target gas in container, presence of gas indicates leak
10/03/2002US20020142466 Controlling ciliary neurotrophic factor cell signaling; obtain cell, incubate with modulator, monitor cell signaling activity
10/03/2002US20020142456 Protein for use in the treatment of body weight defects
10/03/2002US20020142453 Optical amplification of molecular interactions using liquid crystals
1 ... 2737 2738 2739 2740 2741 2742 2743 2744 2745 2746 2747 2748 2749 2750 2751 2752 2753 2754 2755 2756 2757 ... 3937